Crescent Biopharma (CBIO) Q4 2025 Earnings

6NovConfirmed
Q3 2023
Q2 2025
Q3 2025
Q4 2025
-5
-3.35
-1.69
-0.04

Details

Expected EPS
-1.958967
Actual EPS
-1.27
Surprise EPS
0.69
Surprise Percent
+35.17%

Description

Crescent Biopharma (CBIO) has reported earnings of -1.27 per share for Q4 2025.

0 Comments

Share your thoughts